Pharmabiz21m
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...
Pharmabiz51m
Piyush Goyal urges pharma industry to leverage ANRF fund for innovation at 63rd Annual Day Celebrations of IDMA in Mumbai
Shardul Nautiyal, Mumbai Monday, February 10, 2025, 14:30 Hrs [IST] ...